Skip to main content
AGMB logo

AGMB

Agomab Therapeutics NV
$13.28 -0.24 (-1.78%) At close · Jul 7
Market Cap
$654.01M
Shares
49,247,975

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
71/100
Short interest 2.2% of shares — P52 Days to cover 9.2 — P90 Short-volume trend +6.1% — P71

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-15). Equal-weight mean of the available factors.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-15 1,069,484 791,046 +278,438 9.16
2026-05-29 791,046 771,266 +19,780 18.43
2026-05-15 771,266 755,022 +16,244 9.04
2026-04-30 755,022 433,265 +321,757 4.39
2026-04-15 433,265 257,073 +176,192 2.06
2026-03-31 257,073 166,639 +90,434 1.30
2026-03-13 166,639 197,864 -31,225 1.99
2026-02-27 197,864 118,033 +79,831 1.57
2026-02-13 118,033 0 +118,033 1.00
Showing 1–9 of 9 settlements
Key facts CIK 2020932 CUSIP 00860C102 13F (30d) 1 filings 1 filers Visit website Investor relations